hyperparathyroidism
HYPERPARATHYROIDISM

Hyperparathyroidism is a condition wherein there is an excessive production of parathyroid hormone (PTH).

Primary hyperparathyroidism is the most common endocrine disorder and an important cause of hypercalcemia in ambulatory patients.

Classic signs and symptoms include bone disease, kidney stones and hypercalcinosis.

Primary goal of pharmacological therapy is to normalize calcium levels.

 

  1. AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologist and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005 Jan;11(1):49-54. PMID: 16033736
  2. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin ENdocrinol Metab. 2014 Oct;99(10):3561-3569. doi: 10.1210/jc.2014-1413. Accessed 08 Nov 2017. PMID: 25162665
  3. Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F. Primary hyperparathyroidism. May 02, 2016. Nat Rev Dis Primers. 2017 Sep. doi: 10.1038/nrdp.2016.33. PMID: 27194212
  4. Cheng V. Hyperparathyroidism. In: Ferri, F F. Ferri's Clinical Advisor 2018. Philadelphia, PA: Elsevier, Inc; 2018. 655-656. :655-656.e1.
  5. Christakis I A, Perrier N D. Evaluation and management of persistent or recurrent hyperparathyroidism. In: Cameron, J L, Cameron A. Current Surgical Therapy. 12th ed. Philadelphia, PA: Elsevier, Inc; 2017. :792-797.
  6. Darr, E A, Sritharan N, Pellitteri P K, et al. Management of parathyroid disorders. In: Flint P W, Haughey, B H, Lund V, eds. Cummings Otolaryngology. 6th ed. Philadelphia, PA: Elsevier, Inc; 2015. 124, 1929-1956.e8. :124, 1929-1956.e8.
  7. Doyle, D A. Hyperparathyroidism. In: Kleigman R M, Stanton B F, St Geme, J, eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier, Inc; 2016. Chapter 573, 2694-2697.e1. :Chapter 573, 2694-2697.e1.
  8. Fuleihan G E. Patient education: Primary hyperparathyroidism (Beyond the basics). UpToDate. http://www.uptodate.com/. Aug 2017.
  9. Fuleihan G E, Silverberg S J. Primary hyperparathyroidism: Diagnosis, differential diagnosis, and evaluation. UpToDate. http://www.uptodate.com. Aug 2017.
  10. Gerden E M. Parathyroid carcinoma. Operative Techniques in Otolaryngology (2009): Elsevier, Inc; 2009. :20, 79-81.
  11. Hindié E, Ugur O, Fuster D, et al. 2009 EANM parathyroid guidelines. May 12, 2009. Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1201-1216. doi: 10.1007/s00259-009-1131-z. Accessed 31 Aug 2017. PMID: 19471928
  12. Maitra, A. The Endocrine System. In: Kumar V, Abbas A K, Aster J C. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Philadelphia, PA: Saunders, an imprint of Elsevier, Inc.; 2015. :1073-1139.
  13. Quinn C E, Udelsman R. The Parathyroid Gland. In: Townsend, C M, Beauchamp, R, Daniel MD, eds. Sabiston Textbook of Surgery. 20th ed. Philadelphia, PA: Elsevier, Inc; 2017. :923-940.
  14. Silverberg S J, Bilezikian J P. Primary Hyperparathyroidism. In: Jameson J L, De Groot, L J, de Kretser, D M, eds. Endocrinology Adult and Pediatric. 7th ed. Philadelphia, PA: Saunders, an imprint of Elsevier, Inc.; 2016. :Chapter 63, 11-5-1124.e6.
  15. Silverberg S J, Fuleihan G E. Primary hyperparathyroidism: Management. UpToDate. http://www.uptodate.com/. Aug 2017.
  16. Taniegra E D. Hyperparathyroidism. American Academy of Family Physician. 2004 2004;69:333-340. http://www.aafp.org/afp.
  17. Wang, T S, Sosa J A. Secondary and tertiary hyperparathyroidism. In: Cameron J L, Cameron A M. Current Surgical Therapy. 12th ed. Philadelphia, PA: Elsevier, Inc; 2017. :798-802.
  18. Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct;151(41):959-968. doi: 10.1001/jamasurg.2016.2310. PMID: 27532368
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 09 Aug 2019
Uric acid-lowering therapy for gout also confers benefits for hyperlipidaemia, with febuxostat delivering greater reductions in cholesterol and triglyceride concentrations in the blood as compared with allopurinol and benzbromarone, according to a recent study.
Roshini Claire Anthony, 08 Apr 2019

About one-third of individuals who achieved remission of type 2 diabetes (T2D) after losing weight with an intensive weight management programme sustained their remission at 2 years, according to long-term results of the DiRECT* trial.

31 Jul 2019
New drug applications approved by US FDA as of 16 - 31 July 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
6 days ago
Chronic exposure to higher cortisol levels among patients with Turner syndrome (TS) is linked to short stature and greater total cholesterol levels, according to a study. Cortisol exposure also contributes to an increase in cardiovascular disease risk.